Relevant Dermatoses Among U.S. Military Service Members: An ...
WARNING! Do Not Consume Alergo Cetrizine : Toxic To Humans And Fatal For Kids
The Health Ministry issued an urgent advisory yesterday to pharmacies, importers and wholesalers of medicine and members of the public that the anti-allergy syrup known as Alergo Cetirizine has been found to be contaminated and should not be consumed.
According to the Drug Regulatory Authority of Pakistan, the contaminated medication was identified in the Maldives and has also been distributed in Laos and Belize. The active ingredient of Alergo Cetirizine is Cetrizine Di-HCI which is an antihistamine. Antihistamine medicines block the effects of a substance called histamine in the body which may cause harmful effects to users.
The Fiji Pharmaceutical & Biomedical Services (FPBS) cannot confirm at this stage on the pharmaceutical companies that have imported the medicinal product into Fiji, and advise members of the public to be vigilant on this matter.
The medicinal product come in 120ml bottles and each 5ml of syrup contains 5mg of antihistamine.
The Alergo Cetirizine syrup is considered to be toxic to humans when consumed and prove fatal especially in children.
Toxic effects can include;
Abdominal pain;
If you have used this medication and show signs of these symptoms, please seek medical advice and report your use of the medicine to the attending medical officer.
Advise to Pharmacists:
The Ministry of Health & Medical Services wishes to advise pharmacists around the country NOT to dispense, distribute or sell this product and to immediately notify Medicines Regulatory Authority (MRA) if the product is in your possession.
Advise to Wholesalers & Retailers:
The Ministry of Health & Medical Services requests wholesalers and retailers to increase surveillance and monitor within the supply chains of countries and regions likely to be affected by these contaminated products.
Advise to Healthcare Professionals:
The Ministry of Health & Medical Services wishes to advise healthcare professionals to report any suspicious cases or symptoms linked to the consumption of this contaminated medication.
For more information please contact: Ilisabeta Pesamino, Chief Pharmacist, Fiji Pharmaceutical & Biomedical Services on 892 1665 or email: FijiMRA@health.Gov.Fj
Ban Placed On Anti-allergy Syrup, Allergo Cetirizine
The ministry is urging people, who have used this medication and show symptoms, to seek medical advice and report consumption of this medicine to medical professionals.
The anti-allergy syrup, Allergo Cetirizine.
The anti-allergy syrup, Allergo Cetirizine is toxic when consumed and will prove fatal in children, warns the Ministry of Health and Medical Services.
In an advisory issued yesterday, the public, pharmacies, importers and wholesalers of medicine were advised that the product was contaminated and should not be consumed.
Studies conducted have found the medicine to include Alergo Cetirizine which is an antihistamine.
Antihistamine blocks the effects of a substance called histamine in the body which can be harmful to users.
Members of the public are further advised to be vigilant particularly because at the moment the Fiji Pharmaceutical and Biomedical Services cannot confirm which pharmaceutical companies have imported the medicinal product into the country.
The anti-allergy syrup comes in 120ml bottles and each 5ml of syrup contains 5mg of antihistamine.
The ministry is urging people, who have used this medication and show symptoms, to seek medical advice and report consumption of this medicine to medical professionals.
Feedback: aralai.Vosayaco@fijisun.Com.Fj
Antihistamine Market Is Projected To Reach At A Valuation Of US$ 647.7 Billion By 2033Future Market Insights, Inc.
Future Market Insights Global and Consulting Pvt. Ltd.
Accelerating Growth in Antihistamines Market Rising Usage of Anti-inflammation Medications on a Global Level. Allergic Disorders in Anticipated to Hold a Significant Share in the Market Studied. North America is Expected to Hold a Significant Share in the Market Over the Forecast Period.
NEWARK, Del, Nov. 20, 2023 (GLOBE NEWSWIRE) -- According to the most recent industry data by Future Market Insights, the global antihistamine market was valued at approximately US$ 263.9 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.6% over the forecast period. By 2033, the market is projected to grow to US$ 647.7 billion.
Antihistamines are medicines that are commonly used for relieving individuals experiencing common symptoms like running nose, sneezing, itchy throat, conjunctivitis, and others. These symptoms are very basic and common ones, so their prevalence is quite high, owing to the increase in the demand for the antihistamine drugs.
Get a Sample Copy of the Report: https://www.Futuremarketinsights.Com/reports/sample/rep-gb-18295
According to WHO, apparently, 262 million people were affected by asthma in 2019. It is a long-term condition affecting both children and adults. Even though it differs from person to person, it includes allergic reactions because of exposure to dust, tree pollen, animal fur, fumes or changes in weather. Antihistamines are certainly not the first-line treatment for asthma, but it helps in alleviating the pain and allergic symptoms that trigger asthma. Medications such as diphenhydramine (Benadryl) and cetirizine (Zyrtec) can be helpful in subsiding the allergic reaction back to its normal track, probably lessening breathing difficulties. This increasing demand would eventually have a positive impact on the growth of the antihistamines market.
The impact of climate change is very evident on human health. The changing temperatures and the pattern of rainfall contribute to various vector-borne diseases, which can develop certain symptoms that lead to swelling and itching. This further stimulates the demand for the antihistamine medications, which help in decreasing the effects of inflammation, owing to the growth of the market.
Story continues
For instance:
In February 2022, TerSera Therapeutics LLC announced the FDA approval for QUZYTTIR as the first and only antihistamine injectable. It is a second-generation H1 antihistamine for the treatment of acute urticarial in children six months of age or above and adults as well.
"Increased availability of over-the-counter antihistamine drugs, as well as increased prevalence of the symptoms related to allergies, is set to propel the sales of antihistamines across the globe," opines Sabyasachi Ghosh, Associate Vice President at Future Market Insights (FMI).
Key Takeaways:
In 2022, H-1 accounted for the highest market share of 55.9% in the antihistamine market.
Over-the-counter antihistamines hold the highest market share of 51.3% in the type category.
Tablets accounted for 35.0% of the market share in 2022. Due to the convenience and effectiveness of oral antihistamine drugs, this segment dominated the market with a 48.2 % market share.
In 2022, the allergies segment led the indication category, accounting for 38.1% of the market.
Hospital pharmacies dominated the distribution channel category with a market share of 42.9%.
North America is considered the leading segment by region, with a market share of 35.0% at the end of the forecast period.
Antihistamines Market Size:
Attribute
Details
Forecast Period
2023 to 2033
Historical Data Available for
2017 to 2022
Market Analysis
US$ billion for Value
Key Regions Covered
North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered
USA, Canada, Brazil, Mexico, Argentina, Germany, France, Italy, UK, Spain, Russia BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, China, Japan, South Korea, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa
Key Market Segments Covered
Product, Type, Dosage Forms, Route of Administration, Indication, Distribution Channel and Region
Key Companies Profiled
GlaxoSmithKline PLC.
Sanofi Consumer Healthcare
Himalaya Wellness Company
Sun Pharmaceutical Industries, Inc.
Bayer AG
Novartis AG
Cadila Pharmaceuticals
Bausch Health Companies Inc.
Alcon Vision LLC.
Merck & Co.
Dr. Reddy's Laboratories, Ltd.
Viatris Inc.
Somerset Pharma, LLC
F. Hoffmann- La Roche Ltd.
Akorn Operating Company LLC
Teva Pharmaceutical Industries Ltd.
Speer laboratories
Glenmark Pharmaceuticals Limited
TerSera Therapeutics LLC
Pfizer Inc.
Morepen Laboratories Limited
Johnson & Johnson Services Inc.
Pharmaceutical Specialties Inc.
Proctor & Gamble
Market Competition
The antihistamine market is highly fragmented in terms of antihistamine types and their different properties of allergies, skin conditions, product quality, and ethnicity. Market players are involved in developing advanced solutions, keeping various factors in mind that can be aligned with the customer's requirements.
In June 2022, Bayer Healthcare LLC received FDA approval for nonprescription Astepro, a nasal antihistamine, for both children above six years and adults.
In July 2020, Alcon Vision LLC. Received approval for the OTC Pataday Once Daily Relief Extra Strength (0.2% antihistamine) for the people in the United States as the first eye allergy itch drop that offers 24 hours of relief.
Buy Now: https://www.Futuremarketinsights.Com/checkout/18295
Key Segments:
By Product:
H-1 Blockers
H-2 Blockers
By Type:
Prescription-based
Over-the-counter
By Dosage Forms:
Tablets
Capsules
Liquids
Other
By Route of Administration:
By Indication:
Allergies
Urticaria
Dermatitis
Other
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Drug stores
Online Pharmacies
By Region:
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore Future Market Insights, Inc. Extensive Coverage in Healthcare Market Domain:
Birch Allergy Treatment Market Analysis: The global market garnered a market value of US$ 571 Million in 2023 and is expected to accumulate a market value of US$ 1123.24 Million by registering a CAGR of 7% in the forecast period 2023 to 2033.
Nasal Antihistamines Market Revenue: By 2023, the market is projected to attain a value of around US$ 2.06 billion, with an expected CAGR of 4.6%. Sales of nasal antihistamines are anticipated to reach a noteworthy US$ 3.23 billion by 2033 potentially.
Pharmaceuticals Excipients Market Forecast: The market is expected to register a CAGR of 6% during the forecast period, up from US$ 7.9 Billion in 2021 to reach a valuation of US$ 10.9 Billion by 2026.
Oxytocic Pharmaceuticals Market Sales: According to Future Market Insights (FMI), the market is likely to generate US$ 114.58 million in revenue in 2023.
Radiopharmaceuticals Market Outlook: According to Future Market Insights (FMI), the market would be worth US$ 6.2 Billion in 2022.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Nandini Singh Sawlani
Future Market Insights Inc.Christiana Corporate, 200 Continental Drive,Suite 401, Newark, Delaware - 19713, USAT: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.ComWebsite: https://www.Futuremarketinsights.ComLinkedInTwitterBlogsYouTube
Comments
Post a Comment